European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate

ConclusionsThere is high-quality evidence of the efficacy of topiramate in the prophylaxis of migraine, albeit its use poses a risk of adverse events that may lead to treatment discontinuation, with a negative effect on patient satisfaction and adherence to care.

http://link.springer.com/10.1186/s10194-023-01671-5

Source: The Journal of Headache and Pain - October 10, 2023 Category: Neurology Source Type: research